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Abstract
The type III secretion system (TTSS) is a key mechanism for host cell interaction used by a variety of bacterial pathogens and
symbionts of plants and animals including humans. The TTSS represents a molecular syringe with which the bacteria deliver
effector proteins directly into the host cell cytosol. Despite the importance of the TTSS for bacterial pathogenesis,
recognition and targeting of type III secreted proteins has up until now been poorly understood. Several hypotheses are
discussed, including an mRNA-based signal, a chaperon-mediated process, or an N-terminal signal peptide. In this study, we
systematically analyzed the amino acid composition and secondary structure of N-termini of 100 experimentally verified
effector proteins. Based on this, we developed a machine-learning approach for the prediction of TTSS effector proteins,
taking into account N-terminal sequence features such as frequencies of amino acids, short peptides, or residues with
certain physico-chemical properties. The resulting computational model revealed a strong type III secretion signal in the N-
terminus that can be used to detect effectors with sensitivity of ,71% and selectivity of ,85%. This signal seems to be
taxonomically universal and conserved among animal pathogens and plant symbionts, since we could successfully detect
effector proteins if the respective group was excluded from training. The application of our prediction approach to 739
complete bacterial and archaeal genome sequences resulted in the identification of between 0% and 12% putative TTSS
effector proteins. Comparison of effector proteins with orthologs that are not secreted by the TTSS showed no clear pattern
of signal acquisition by fusion, suggesting convergent evolutionary processes shaping the type III secretion signal. The
newly developed program EffectiveT3 (http://www.chlamydiaedb.org) is the first universal in silico prediction program for
the identification of novel TTSS effectors. Our findings will facilitate further studies on and improve our understanding of
type III secretion and its role in pathogen–host interactions.
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Introduction
Many Gram-negative bacteria with symbiotic or parasitic
lifestyles modulate their environment, the eukaryotic host cell,
by the secretion of bacterial proteins into the host cell through
the type III secretion system (TTSS) [1]. The unique role of
type III mediated transport for establishing as well as maintaining
infection makes it a key mechanism for bacterial pathogenesis
[2–4]. While much progress on resolving the structure of the
TTSS itself has been made recently [5], the identity and function
of only few effector proteins is so far understood well. These
include different virulence factors, which interact with cell
signaling pathways to suppress immune response by inducing
apoptosis in macrophages as the Yersina effector YopJ or the
Salmonella effector SipB [6,7]. Other known effectors manipulate
the cytosceleton by actin re-arrangements as described for the
Salmonella effector SipA [8]. The arsenal of known effectors varies
widely between different bacterial species due to adaptation to
different hosts and different survival strategies [9] and even
between different strains of the same organism as shown for
Pseudomonas syringae [10].
Experimental identification of novel effectors relies on translo-
cation assays using fusion proteins of a putative effector with a
reporter gene [11–14] or detection of effectors in the culture
supernatant [11]. In many of these studies, prior information is
derived computationally from the genome or from protein
sequences to create candidate lists of putative effectors before
testing them in an appropriate assay. Homology to known effector
proteins has been used in a screen for effectors in the pathogenic
Escherichia coli strain O157 [11]. Chromosomal co-localization of
putative effectors with TTSS related chaperons has been used in
Bordetella bronchiseptica [15]. Common transcriptional regulation
with elements of the TTSS has been exploited to detect putative
effectors in P. syringae [13,16]. In the same organism, an unusual
amino acid composition in the N-termini of effectors has been
identified as a characteristic of effector proteins and used for their
identification [16–18].
In all these approaches, the computational analysis successfully
limited the amount of candidates which had to be included in
experimental analyses in order to find novel effectors. However,
none of these methods is either exhaustive or generally applicable.
Homology based approaches can only detect effectors which are
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for certain well-known bacterial species. Approaches using
transcriptional co-regulation need knowledge about a TTSS
effector specific promoter which has not yet been described for
most bacteria possessing a TTSS. The unusual amino acid
composition in the effector N-termini has to date only been
described and exploited in screens in P. syringae. Chromosomal co-
localization is only applicable if effectors and TTSS related
proteins or chaperones are clustered in genomic proximity as
described for the pathogenicity islands in Salmonella [19]. However,
these pathogenicity islands are absent in other bacteria known to
harbour a TTSS such as the Chlamydiae, where the genes encoding
known effectors are scattered around the genome [20,21].
In order to create a general method for the prediction of type III
secreted proteins, the most straightforward way would be the
identification of a general molecular signal which leads to specific
recognition of effector proteins by the TTSS. The molecular
structure of such a secretion signal is, however, so far unknown.
The binding of specific chaperons has been shown to be necessary
in some cases [22] but does not seem to be a general prerequisite.
Several studies indicate a signal in the N-terminus either encoded
in the underlying mRNA [23,24] or in the peptide [12,25,26].
Subtil et al., for example, successfully screened for TTSS effectors
using fusion proteins consisting of a chlamydial N-terminus and a
reporter gene in a heterologous Shigella flexneri assay [12]. This
experiment showed that the first 15 amino acids are sufficient for
the secretion of several chlamydial effectors.
In this work we demonstrate that information derived from N-
terminal peptides is universally applicable to successfully predict
type III secreted proteins. We have implemented EffectiveT3, the
first general prediction software for type III effector proteins. This
software is based on a machine learning approach and can be
applied to single proteins as well as complete proteomes. We
investigate the molecular shape (i.e., length, position, composition)
of the signal captured by the EffectiveT3 software and demon-
strate that the signal is taxonomically universal. We applied the
EffectiveT3 software to 739 prokaryotic proteomes and discuss the
sizes of predicted secretomes.
Results/Discussion
Common features of known effector proteins
To comprehensively investigate the nature of the TTSS signal,
we compiled a database of known effector proteins from members
of the phylum Chlamydiae and the genera Escherichia, Yersinia and
Pseudomonas by an exhaustive mining of literature. These ‘‘animal
pathogen’’ and ‘‘plant symbiont’’ sets consist exclusively of
proteins with individual experimental evidence for type III
mediated transport and comprise 100 proteins including 48
effectors from animal pathogens/symbionts and 52 effectors from
plant symbionts (Table S1). 39 of them can be clustered by
sequence similarity into 15 distinct orthologous groups (see Table
S2). These orthologous groups, however, turned out to be
restricted to their respective taxon. Their members have no
counterparts with significant homology over the major part of
their sequences in other organisms included in this study.
To investigate whether predicted functional interactions based
on genomic context methods [27] could be used for the prediction
of TTSS effectors, we analyzed all known effectors using the
STRING database [28]. A few cases of conserved chromosomal
neighbourhood of effectors with structural TTSS proteins or
chaperones could be observed, whereas most effectors do not co-
evolve with the TTSS (Table S3). The genomic neighbourhood of
known effectors has been further examined by statistical analysis of
all co-localized proteins. Components of the TTSS are signifi-
cantly enriched in the proximity of effectors (Table S4). The
highest significance of this enrichment has been observed within
the range of 30 proteins up- and downstream. Within these
neighbours, 7 structural TTSS proteins show individual enrich-
ment of statistical significance (Table S5). However, particularly in
genomes encoding the TTSS on the chromosome as e.g.
Chlamydiae, the majority of effectors cannot be found in genomic
proximity to components of the TTSS (Table S6). Thus we cannot
derive a general co-evolution rule for all effectors, which limits the
predictive power of genomic context methods significantly.
However, the observed co-evolution of certain effectors with each
other and the co-localization of several effectors with TTSS
components and chaperones make this methodology valuable for
situations if such effectors or chaperones are already known or if
the TTSS is encoded on a plasmid or on a genomic island.
In a next step we analyzed the N-terminal amino acids of known
TTSS effectors in greater detail. Within their N-terminal peptides,
the effectors did not show any conserved residues in several
multiple sequence alignments performed and analyzed (see Figure
S1 for an example). The absence of conserved positions indicative
of a common sequence motif or domain signature, which could
serve as a signal, demonstrated that a conserved binding domain
can be excluded as a general TTSS signal.
A secretion signal could also be encoded in the secondary
structure of the N-terminus. We employed secondary structure
predictions and counted the structural features (coil, a-helix, b-
sheet) at each residue within the first 25 amino acids. In the known
TTSS effectors, 51% coil, 39% a-helix and 10% b-sheet have
been predicted. In randomly selected proteins (not known to be
secreted via a TTSS) we predicted 39% coil, 45% a-helix and
16% b-sheet, which indicates that coiled regions are enriched in
the N-termini of TTSS effectors.
These findings fit well with data from P. syringae, a well-studied
plant pathogen, for which an unusual amino acid composition in
the N-termini of effectors has been reported [16–18,29]. Therefore
Author Summary
Many Gram-negative bacteria live closely associated with
humans, animals, or plants. The pathogenic or symbiotic
interactions between bacteria and host are often mediated
by the secretion of bacterial proteins into the host cells.
The Type III secretion system (TTSS) is one of the best
studied cellular machineries for this purpose and is able to
specifically recognize and export effector proteins, which
are injected into the eukaryotic cells through a needle-like
structure. However, neither the mechanism of transport
nor the recognition of proteins to be exported via the TTSS
has so far been fully comprehended. In this study we have
developed the first general computational model that is
able to identify TTSS effector proteins based on the
analysis of a short part of their amino acid sequences. The
features of this signal sequence are universal among
human and animal pathogens and plant symbionts. Based
on our findings, we developed a computer program for
the in silico prediction of TTSS effector candidates; for
example, in new genomes. The TTSS and its effector
proteins constitute a central virulence mechanism of
several bacterial pathogens responsible for severe and
widespread infectious diseases in humans and animals.
Our findings will facilitate and improve further investiga-
tions of TTSS-mediated pathogenesis and its role in
pathogen–host interactions.
Prediction of Type III Effectors
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general feature of effector proteins. A Mann-Whitney test on
amino acid frequencies derived from both the whole sequences
and the first 25 residues of the N-termini from the effector sets and
randomly selected proteins revealed significant enrichments and
depletions of certain amino acids in sequences from animal
pathogens and plant symbionts, respectively (Figure 1). This effect
is particularly strong in the N-terminal end and therefore, this
composition bias could reflect an exploitable signal of TTSS
mediated transport. The most significant enrichment in the N-
termini of effectors of animal pathogens and plant symbionts is
that of serine. Threonine and proline are significantly enriched in
the effectors of animal pathogens, and leucine is depleted in both
animal and plant effector proteins. Notably, the enrichment of
proline could explain the enrichment of coiled regions in the N-
termini as this amino acid is known to be less frequent in a-helices
and b-sheets. Interestingly, these experiments revealed both
commonalities and differences between the N-terminus of effector
proteins from plant and animal pathogens, respectively.
Modeling of the N-terminal TTSS signal peptide using a
machine learning approach
The evidence for an unusual amino acid composition in the N-
terminus of known TTSS effectors and the lack of a common
sequence motif or domain signature prompted us to use a machine
learning approach based on a binary classifier to model the TTSS
secretion signal. Binary classification algorithms, such as the naive
Bayes algorithm [30], are trained by a positive and negative set of
instances, each instance represented by a vector of features. The
algorithms weight each feature (or combinations of them) during
the training process in order to achieve optimal separation
between the positive and negative sets. If the performance of the
classifier is high, these weights should represent the underlying
biological signal. Based on our analyses of the TTSS effector sets,
we represented each sequence by a collection of features
comprising frequencies of amino acids, amino acid properties
and short combinations of them (see material and methods). In an
alternative attempt, we used features derived from the predicted
secondary structure elements. Subsequently, the performance of
the different classification algorithms and strategies was assessed by
10-fold cross-validation (see material and methods). The ‘‘Area
Under the Curve’’ (AUC) value of the Receiver Operating Statistic
Curve (ROC) represents the performance of a classifier describing
the trade-off between sensitivity and selectivity by varying over the
classifier’s parameter space. The AUC summarizes this overall
performance: an ideal classifier yields an AUC of 1.0, whereas a
completely random prediction results in a value of 0.5. Values
above 0.5 indicate a prediction above random.
A systematic comparison of different classification algorithms on
the TTSS effector sets from animal pathogens and plant
symbionts, respectively, resulted in a performance far above
random for all classifiers tested, with an maximal AUC of 0.85 for
the animal pathogen set and an AUC of 0.86 for the plant
symbiont set, achieved by the complement naı ¨ve Bayesian
algorithm. Both sets combined together achieved their best AUC
(0.86) with the Naı ¨ve Bayesian classifier (Table 1). Training the
classifier solely on the predicted secondary structure alphabet of
the combined set performed well with an AUC value of 0.8.
However, adding this alphabet to the sequence derived features
did neither improve nor reduce the performance significantly: the
test revealed an AUC of 0.87 with and 0.86 without the secondary
structure features. A selection of the most discriminating features
(see material and methods) resulted in a reduced list of features.
These comprise not only the serine, proline and threonine
Figure 1. Enrichment of amino acids in effector N-termini. Amino acids that are significantly enriched or depleted in the first 25 residues of
effectors from the animal pathogen effector set and from the plant symbiont effector set (p-Value,0.05 in the one sided Mann-Whitney test in at
least one of the sets). Frequencies are given as percentage of amino acids within the 25 first residues. Error bars represent one standard deviation in
plus and one standard deviation in minus directions.
doi:10.1371/journal.ppat.1000376.g001
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analysis, but also depletion of acidic and single alkaline residues
and patterns such as the enrichment of two consecutive alkaline
residues or the pattern ‘‘polar-hydrophobic-polar’’ (Table 2).
To define the part of the proteins which contributes most to the
signal, we performed two experiments: First, we varied the length
of the N-terminal peptide included in the analysis in order to
detect the signal’s length and secondly, we scanned different start
positions of 15 residue long windows. For each selection of length
and position, the complete feature creation, training and testing
procedure was repeated. The results for these two experiments are
shown in Figure 2. As high AUC values are reported over a wide
range of N-terminal peptide lengths, with only a slight maximum
peak at length 30 in the animal pathogen and length 50 in the
plant symbiont set, the actual length of the signal is difficult to
determine. However, the position scan revealed that the most
discriminating positions are indeed at the N-terminus followed by
a region with less predictive power. The best performance was
achieved with the residues 0–30 in the plant symbiont and 0–50 in
the animal pathogen set of effector proteins. Notably, also the
selection 0–15 in both sets gives a good discriminative power.
Some other positions (e.g., residues 90–105 and 120–135 in the
plant symbiont set) also show (an indeed weaker) predictive power
which could hint to an additional signal or at least regularity in
these regions. The majority of positions, however, have no
predictive power due to AUC values between 0.4–0.6, and using
the 15 C-terminal residues also resulted in an AUC value
comparable to a random prediction (Table S7).
Taken together, these findings show the existence of a common
signal encoded in the N-termini of TTSS effector proteins and are
in agreement with the N-terminal signal peptide theory [23,24].
Although it cannot be described by a pattern of conserved amino
acid residues, the signal comprises a characteristic amino acid
composition bias, and can thus be computationally captured using
a machine learning approach. Predicted secondary structure
elements show predictive power, but are substitutable by the
sequence derived features. Therefore, secondary structure features
are likely to be part of the signal, but are equally reflected in the
sequence composition.
The TTSS signal peptide is taxonomically universal
The successful applications of heterologous TTSS systems for in
vitro screens [11–14] indicate that the TTSS secretion signal is
universally understood among phylogenetically different microor-
ganisms. The enrichment and depletion of specific amino acids in
the N-termini of effectors supports this hypothesis, since the same
amino acids are either depleted or enriched in the animal
pathogen and plant symbiont sets (Figure 1) except for minor
Table 1. Performance of different classification algorithms for the prediction of TTSS effectors.
Algorithm Sensitivity sd Selectivity sd AUC sd
Animal pathogen set
Naı ¨ve Bayes complement [57] 0.77 0.02 0.79 0.04 0.78 0.02
1 nearest neighbour [58] 0.54 0.09 0.81 0.04 0.68 0.07
Logistic regression [59] 0.57 0.07 0.75 0.07 0.72 0.08
Naı ¨ve Bayes [30] 0.71 0.03 0.85 0.04 0.85 0.03
Naı ¨ve Bayes multinomial [60] 0.76 0.03 0.81 0.04 0.85 0.02
Support vector machine [61] 0.57 0.05 0.86 0.04 0.71 0.04
Voted perceptron [62] 0.24 0.04 0.97 0.02 0.78 0.01
Plant symbiont set
Naı ¨ve Bayes complement 0.79 0.03 0.77 0.03 0.78 0.03
1 nearest neighbour 0.60 0.04 0.80 0.04 0.69 0.04
Logistic regression 0.62 0.03 0.74 0.06 0.73 0.03
Naı ¨ve Bayes 0.81 0.02 0.77 0.03 0.84 0.01
Naı ¨ve Bayes multinomial 0.78 0.03 0.78 0.03 0.85 0.02
Support vector machine 0.66 0.04 0.83 0.04 0.74 0.03
Voted perceptron 0.28 0.10 0.96 0.03 0.79 0.04
The performance of different classification algorithms in a tenfold cross-validation on the animal pathogen and plant symbiont training set is shown. The cross-
validation has been repeated five times with different negative sets that were randomly chosen from the respective organisms. Sensitivity (defined as TP/[TP+FP]),
selectivity (defined as TN/[TN+FP]), and the AUC value are given with their standard-deviation (sd) computed from the five runs.
doi:10.1371/journal.ppat.1000376.t001
Table 2. Most discriminating features between positive and
negative instances.
Pattern Enriched/Depleted
Polar–hydrophobic–polar Enriched
Alkaline–alkaline Depleted
Threonine Enriched
Serine Enriched
Proline Enriched
Polar Enriched
Alkaline Depleted
Acidic Depleted
Hydrophobic–alkaline Depleted
Polar–polar Enriched
The most discriminating features as reported by the feature selection
procedure. Enrichment or depletion is indicated in respect to the effector class.
doi:10.1371/journal.ppat.1000376.t002
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conservation of the type III secretion signal, we conducted the
following experiment: We tested the performance to detect effector
proteins in genomes which were not part of the training set and
thus did not contribute in the feature selection procedure. For this,
we systematically excluded genomes from training and tested the
classifiers’ performance not by cross-validation, but on the
excluded sequences. High AUC-values between 0.83 and 0.89
were observed for all tested combinations (Figure 3, individual
results of all effectors in Table S8). Notably, it was possible to
predict effectors from the animal pathogen set when trained by the
plant symbiont set and vice versa, yielding an AUC of 0.86 and
0.83 respectively. Therefore, the captured signal is not organism
specific but must be taxonomically universal.
Evolutionary history of the TTSS signal peptide
Since the N-terminal TTSS signal is universally detectable, we
tested, whether its acquisition during evolution also follows a
regular pattern. We investigated this by comparing validated
effector proteins with their orthologous counterparts in organisms
without TTSS. If a regular acquisition of the signal peptide by N-
terminal fusion events occurs, this should be reflected in a regular,
N-terminal extension of effector proteins compared with their non-
effector orthologs. To test this, we performed two experiments: a
systematic multiple sequence alignment approach of effectors and
orthologs which are sure non-effector sequences and a pair wise
sequence alignment analysis, in which individual elongations and
truncations between effectors and non-effector orthologs were
assessed.
In total, we could build alignments for 10 orthologous groups
containing effector proteins and sure non-effector proteins. A
manual inspection of the multiple alignments did not reveal a clear
pattern which would support regular fusion events. This result is
further supported by the pair wise analysis: Elongations of the
effector sequences compared to non-effectors are less frequent
(30%) than truncations (57%), whereas a similar length of effector
and non-effector occurs in 13% of all pairs (Table S9, Figure S2).
All three events can be detected within the same orthologous
group. HopAK1, a Pseudomonas syringae effector, is the only example
which is more often elongated (three cases) than truncated (one
case). A similar picture can be seen when only the length of the N-
terminal regions before the first common functional domain of
effector and non-effector orthologs were compared: N-terminal
regions with equal lengths can be found in 4%, shorter lengths for
the effector in 39% and longer lengths for the effector in 57% of
cases (data not shown).
For elucidating the evolutionary acquisition of the TTSS signal
peptide we therefore suggest a model of convergent sequence
adaptation. Under the selective pressure of a type III secretion
system, the N-terminal sequences of all proteins which are exposed
to translocation (e.g., by their cellular localization and transcrip-
tional regulation) have adapted towards or against translocation
and thus became effectors or non-effectors. Such a convergent
evolutionary acquisition is in congruence with the absence of
sequence homology between most of the known type-III effectors.
Inadditiontothisgeneralmechanism,singularterminalre-assortment
Figure 2. Exploration of position and length of the signal. Exploration of optimal length of the signal (A) and begin position of a 15 amino
acid long window (B). The AUC value for each length and begin position is plotted for the animal pathogen set (red) and the plant symbiont set
(green).
doi:10.1371/journal.ppat.1000376.g002
Figure 3. Taxonomic universality of the signal. The y-axis denotes
the achieved AUC value of EffectiveT3 when trained without the
positive and negative samples from the taxonomic group denoted at
the bottom of the x-axis and tested against this set. The performance
on a randomly chosen set of positives and negatives having the same
taxonomic composition is given for comparison.
doi:10.1371/journal.ppat.1000376.g003
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accelerate the acquisition of TTSS signal peptides.
The signal is robust against point mutations and can
even tolerate frame shifts
Our in silico model of the N-terminal secretion signal allows the
simulation of its robustness against point mutations. In a first
experiment, we exchanged residues accumulatively by random.
The signal turned out to be robust when changing arbitrary
residues: after one point mutation 97% after five 75% and after
ten 54% of the effector proteins still have a detectable signal
(Figure S3). In a second experiment, we favoured to exchange
these features, which we found to have the strongest influence on
the signal. For example, we depleted the amount of serine and
threonine and exchanged them in favour of arbitrary residues. In
this procedure, the signal rapidly breaks down: after one mutation
93% of the effectors, but only 27% after five and 2% after ten
mutations carry a detectable signal (Figure S3). Therefore, the
signal is robust against single and multiple point mutations as long
as the significant enrichments and depletions of certain amino
acids are not altered.
Schneewind and coworkers [32] showed that frame shift
mutations in the mRNA altering the N-terminal peptide sequence
did not abolish transport of three TTSS effector proteins of Yersinia
species. This seems to contradict the N-terminal signal peptide
hypothesis but could be explained, if the frame shifts lead to
altered amino acids in the N-terminus, which nevertheless retained
the characteristic features of the TTSS signal. Nine example frame
shifts are given in this study which did not abolish secretion. One
Yersinia protein (YopQ) could not be predicted as effector by our
method and thus represents a false negative prediction. From the
remaining six frame shifts in two proteins (YopE and YopN), only
the 22 frame shift of the YopN N-terminus did not lead to a loss
of the TTSS signal. The same behaviour has been shown for the
Salmonella effector InvJ which tolerates +1 and 21 frame shifts
[33]. In the case of the +1 frame shift the signal is still revealed by
EffectiveT3, whereas no signal can be detected for the 21 frame
shift. In order to assess the sensitivity of the TTSS signal towards
frame shift mutations in a more systematic manner, we artificially
introduced all possible frame shift mutations into the 74 known
and positively predicted effectors. As control, we applied the same
procedure to a set of 199 randomly selected and negatively
predicted control sequences. In 15 cases (10%) of the effector
mutants, the signal was preserved (Table S10), in contrast to 31%
of the control sequences (data not shown). This unexpectedly high
rate of preservation in non-effector mutants results from specific
amino acid enrichments and depletions in the mutated sequences,
which are very similar to the characteristics of TTSS effectors
(data not shown). Surprisingly and in agreement with the mRNA
signal hypothesis [23,24], three effector sequences are resistant to
both kinds of shifts, the +1 and +2 mutations (Table S10). Taken
together, our data suggests that while some TTSS effectors
surprisingly tolerate frame shifts without losing the amino acid
secretion signal, most of the known effectors are sensitive towards
frame shift mutations.
A substantial fraction of proteomes is predicted as
secreted
To predict type III secreted proteins for whole genomes, we
applied our software EffectiveT3 on 739 bacterial and archaeal
proteomes. We chose all completely sequenced prokaryotes for
which the presence or absence of a type III secretion system could
be determined using the KEGG database [34] and for which the
cell wall type (Gram-negative vs. Gram-positive) has been
unambiguously described (Table S11). In organisms encoding a
TTSS, a substantial fraction of proteins is predicted as secreted,
varying between 2% and 7% percent with an average of 4% of all
proteins. In organisms without a TTSS, the fraction of positive
predictions varies widely between different taxonomic groups.
Gammaproteobacteria without a TTSS mostly contain a less or similar
percentage of positives as Gammaproteobacteria with a TTSS.
Interestingly also Deinococci (6%) and the Gram-positive Actinobac-
teria (up to 10%) exhibit high percentages of positives despite the
differences in cell wall composition and the absence of a TTSS.
Contrarily, Archaea and Firmicutes exhibit a very low amount of
positives with 1%, respectively 2% on average. Between more
closely related bacteria, similar percentages of predicted TTSS
effectors were found in different strains of e.g. S. enterica (on
average 3%) and E. coli (3%). The amoebae symbiont Proto-
chlamydia amoebophila exhibits a slightly higher percentage (6.1%)
compared to its chlamydial relatives, which are pathogens of
animals and humans (on average 5%).
The surprisingly high number of (false) positives in genomes
without TTSS exceeds the expected false positive rate (Table 1)
and thus raised questions about their nature. Manual inspection of
positive predictions in Gram-positive bacteria revealed many cases
of wrongly annotated gene starts (having N-terminal elongations
and thus contain fractions of the intergenic space) or questionable
genes without any homologs in other genomes (ORFans).
Although genome annotation errors have many different reasons,
they are more likely in G+C rich genomes due to the long average
lengths of open reading frames [35]. When comparing the number
of positives with the genomic G+C content, a partially linear
relationship can be seen for Gram-positive bacteria (Figure 4;
R
2,0.4). In agreement with the mutation experiments (see above),
which showed similar characteristics of the N-termini from
effectors and many nonsense peptides after frame shift mutations,
unexpectedly high fractions of positives in Gram-positives are
likely to be artefacts from misannotations. To distinguish between
wrongly annotated gene starts and ORFans, we assessed the
specificity of positive predictions for N-terminal sequences by
calculating a genome wide Z-Score (see material and methods).
Proteomes with a high Z-Score (.1) are enriched in effector-like
sequences in the N-termini. Low Z-Scores indicate the presence of
ORFans, which show similar characteristics to type III effectors
over their whole length (Table S11).
In Gram-negative bacteria, the correlation between the number
of positives and the genomic G+C content is much weaker
(R
2,0.06) than in Gram-positives (Figures 4 and 5). Additive to
the expected false positive rate, most proteomes with TTSS
encode more putative effectors than their relatives without TTSS.
The missing clear difference between Gram-negatives with and
without TTSS may be explained by the noise caused by
misannotations which seem to be present in all selected genomes
(data not shown). Additionally, putative Type III effectors may not
be a unique feature of species encoding a TTSS but could be
ubiquitous in a broad range of phylogenetically diverse microbes.
This finding would be surprising, but could be explained by the
absence of evolutionary pressure on N-termini towards not to be
secreted in microorganisms without a TTSS. Additionally, effector
proteins might be subject of horizontal gene transfers into genomes
without TTSS where they neo-functionalize but keep their N-
termini.
Conclusion
The TTSS is a key virulence factor in many important human
pathogens, such as Salmonella sp., Yersinia sp., Chlamydiae and E. coli.
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percentage of positive predictions in proteomes from Gram-positive bacteria and archaea, respectively, depending on the G+C content of the
genomes. Linear fits are shown by trend lines in the colours of the respective data sets; attached are the coefficients of determination R
2 of each fit.
The individual results for all proteomes can be found in Table S11.
doi:10.1371/journal.ppat.1000376.g004
Figure 5. Overview of EffectiveT3 predictions in complete genomes from Gram-negative bacteria with and without TTSS. The figure
shows the percentage of positive predictions in proteomes from Gram-negative bacteria with and without TTSS, depending on the G+C content of
the genomes. The plot has been scaled as Figure 4 to facilitate comparison. Linear fits are shown by trend lines in the colours of the respective data
sets; attached are the coefficients of determination R
2 of each fit. The individual results for all proteomes can be found in Table S11.
doi:10.1371/journal.ppat.1000376.g005
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so far only on a small taxonomic scale, impeding the study of
this important group of virulence factors in newly sequenced
genomes of organisms without well-studied close relatives. In this
study we describe the identification of taxonomically universal
features of TTSS effector proteins, which formed the basis of the
development of the program EffectiveT3, the first universally
applicable in silico prediction method for TTSS transported
proteins.
The core of our in silico prediction method consists of a machine
learning approach, which behaves like a black-box in the sense
that it does not imitate the unknown biological mechanism itself
but models regularities in the N-terminal peptides of TTSS
effectors. Since the training set comprised no other common
feature beside TTSS mediated transport, EffectiveT3 must
capture the sequence related parts of the biological signal. In
contrast, it has not been possible to learn on equally sized,
randomly selected sequences using the same machine learning
protocol. Thus the predictive performance cannot result from a
selection bias introduced by small training sets.
EffectiveT3 performs far above random in the cross-validation
as well as on data derived from organisms which were not present
in the training set. A certain degree of generality of the TTSS
substrate recognition process was already suggested by heterolo-
gous secretion assays [12]. Our computational model demon-
strates that the signal is indeed highly conserved over a broad
taxonomic range, facilitating the prediction of plant symbiont
effectors using information derived from animal pathogens (and
vice versa). This taxonomic universality of the TTSS secretion
signal implies a common mechanism of TTSS substrate
recognition across phylogenetically diverse bacterial groups.
The great value of the EffectiveT3 method is its independency
from sequence similarity to known effectors and the independence
of organism specific a priori knowledge. It is therefore suited to the
application on newly sequenced genomes from bacteria with a
Gram-negative type cell wall and for the detection of novel effector
families, which could lead to the discovery of so far unrecognized
virulence factors and thus improve our understanding of the ways
of host cell manipulation by bacterial pathogens. Since the
procedure reveals a substantial fraction of false positive predictions
and is intrinsically sensitive to misannotations such as wrongly
annotated gene starts and ORFans, the current method should be
complemented by specific pre- and postprecessing steps:
1. Before applying EffectiveT3, the gene annotations of the
analyzed proteins should be verified to remove ORFans and
ensure correct translational start sites.
2. An additional protocol to filter and rank the positive
predictions by reliability might include the exclusion of already
annotated genes, house-keeping genes and proteins with a
signal for other transport routes as the SecA pathway.
3. Particularly in genomes which encode TTSS components on
plasmids or genomic islands, the genomic proximity of TTSS
components might be enriched in effectors and should be
analyzed additionally.
The most promising improvement of our computational model
would be the consideration of the transcriptional control of
effector proteins [36]. It can be expected that genome-wide
transcriptional data will become available in the near future for a
sufficient number of genomes having known type III effectors.
The EffectiveT3 predictions can be accessed online at http://
www.chlamydiaedb.org. The software is freely available from the
authors upon request.
Materials and Methods
Data sets
The known type-III effector proteins have been collected
manually from the literature. Each protein has been included if it
has at least one direct evidence for TTSS mediated transport
resulting from a single experiment. Not included are proteins,
which are part of the TTSS needle complex although some of
them are transported by the TTSS and data from large scale
screens. By this procedure, we collected a animal pathogen set of
48 proteins comprising the taxa Chlamydia (17 sequences),
Salmonella (9 sequences), Yersinia (15 sequences), Escherichia (7
sequences). A representation of this set with only one member of
each orthologous group has been created separately. The
sequences were downloaded from SWISSPROT/UNIPROT
[37] (version as downloaded on 07/30/2008) or, if not contained
there, downloaded from RefSeq [38] (version as downloaded on
07/30/2008). We retrieved the plant symbiont set consisting of 52
known Pseudomonas effector proteins from the Pseudomonas syringae
Genome Resources database [39] (Hop virulence protein/gene
database, downloaded on 07/30/2008). A complete list of used
effector sequences is given in the Table S1. All effectors have been
examined for correctness of translational start sites by manual
inspection of multiple sequence alignments with their homologs.
Negative training sets of non-effectors have been created by
randomly choosing proteins from the organisms represented in the
animal pathogen and plant symbiont sets devoid of the known
effectors. Each negative set is twice as large as its corresponding
positive set. This procedure has been repeated five times in order
to enable investigations on the influence of the negative set on the
prediction.
Protein sequences from completely sequenced genomes of
Yersinia, Escherichia, Salmonella, Pseudomonas, Chlamydia species as
well as of gram(+) Bacteria, Archaea and Gammaproteobacteria were
downloaded from RefSeq (version as downloaded on 07/30/2008)
[40]. The data sets were classified into organism with and without
TTSS by manual search in the literature for the case of gram(2)
bacteria or generally classified as ‘‘without TTSS’’ in the case of
gram(+) bacteria and archaea. A complete list of organisms used is
given in the Table S11. A list of proteins building the TTSS system
has been obtained by full-text searches against the SIMAP [41]
databases using the gene-names of the TTSS compounds as given
by KEGG [34].
Grouping of training sets by homology
An all-against-all comparison of the full length-sequences using
the Smith-Waterman algorithm [42] as implemented in the
Jaligner package was performed [43]. For each pair, a similarity
score Sratio by dividing the alignment score by the selfscore is
computed and sequences are iteratively grouped if they show a
Sratio value greater or equal 0.15. This measure is similar to the
measure used by Lerat et al. in a study of genome repertoires in
bacteria [44] and has been adjusted to maximal sensitivity in the
detection of putative orthologs.
Secondary structure prediction
To predict secondary structure features we used the PSIpred-
software [45]. The prediction has been applied to the whole
sequences. PSIpred can be applied using alignments to conserved
sequences as extrinsic information using PSI-BLAST [46]. For this
purpose, we performed PSI-BLAST searches against SWIS-
SPROT/UNIPROT. For the N-terminal ends of the effectors,
we did not receive a sufficient amount of alignments to improve
the secondary structure prediction at these positions. As a
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alignment information. We then counted the fraction for each
predicted class in the N-termini as input feature for the prediction
pipeline.
Multiple alignments of N-termini
Multiple alignments have been created using two different
methods: ClustalW (Version 2.0.5) [47], and Muscle (Version 3.7)
[48] with standard parameters. We randomly chose ten sequences
from the sets of known effectors to create multiple alignments and
aligned their 10, 20 and 30 first residues. This procedure has been
repeated 20 times. We manually checked the alignments for
conserved regions similar to a multiple alignment containing a
certain domain signature. Example alignments are given in the
Figure S1.
Statistical enrichment analyses
Enrichments and depletions of amino acid properties (frequen-
cy, frequency of its representations in a reduced alphabet,
frequency of secondary structure properties) have been performed
using a one sided Mann Whitney test with p,=0.5. We used the
implementation in the Prompt software (Protein Mapping and
Comparison Tool [49], which employs the statistic software R
[50].
Co-evolution of known type-III effectors and TTSS-related
sequences
Predicted functional interactions between orthologous groups
containing effector sequences and selected TTSS sequences
(representing proteins of all orthologous groups taken from Table
S1) were obtained from the STRING database [28] (Version 7.1
as downloaded on 10/03/2007). Links from genomic context
methods (conserved neighbourhood, gene fusion, phylogenetic
profiles) were used, the others were discarded. Links with a
confidence score less than 0.5 have been discarded and the
connected proteins were grouped.
For the in-depth analysis of conserved genomic proximity,
complete genome and proteome data for the known effectors has
been downloaded from the KEGG database [34] (release 2009/
01/19). Components of the TTSS have been identified by their
association to the KEGG Orthologous Groups (KO) belonging to
the TTSS reference pathway KO03070 (K03219..K03230).
Genomic neighbours of a certain distance to known effectors
have been extracted from the KEGG data and grouped by their
associated KO.
Analysis strategy for signal acquisition
To detect regular acquisition by fusion of a signal peptide, we
employed an automated alignment pipeline. Orthologous groups
have been obtained from the eggNOG database [51] for each
effector protein. Proteins from organisms other than Gammaproteo-
bacteria have been filtered out. The remaining proteins where
labelled as ‘‘effector’’ if in training set, ‘‘putative effector’’ if from
an organism with TTSS or ‘‘non-effector’’ if from an organism
without TTSS.
We cut every sequence at the start of its first functional domain
as detected by Pfam [52] (as contained in InterPro Release 17.0
[53]) and created multiple alignments of the remaining N-terminal
fragments. We then checked the alignments for regular N-terminal
extensions of effector or putative effector proteins compared with
non-effectors by manual inspection in the case of the multiple
alignments. We also pair wise aligned effector/non-effector
sequences from the same orthologous group and counted
elongations (alignment start of the effector greater than of the
non-effector) and truncations within one group. If the difference
between the alignment starts was smaller than 15 residues, we
counted the alignment as having the same length. The same
procedure has been repeated without aligning the sequences by
just comparing the lengths before the start of the functional
domain.
Multiple alignments were built using ClustalW (Version 2.0.5)
[47], Muscle (Version 3.7) [48], with standard parameters, pair
wise alignments were calculated with the Smith Waterman
algorithm as implemented in the Jaligner package using the
BLOSUM62 substitution matrix.
Feature creation
We deduced the frequencies of amino acids as well as
frequencies from two reduced alphabets. The reduced alphabets
are created by mapping amino acids to amino acid properties and
to a hydrophobic/hydrophilic alphabet. Each amino acid is only
added to one of the property classes, although some would fit to
several classes. In this case, the amino acid has been added to the
more specific (smaller) class. The feature mapping is listed in
Table 3. We also computed the frequencies of di- and tri-peptides
from each of the alphabets. From these features, we discarded all
these which did not occur at least two times in either the positive
or the negative data set, since these features would lead to the
adaptation of the classifiers to individual sequences (over-fitting).
This procedure typically reveals ,70 features, depending on the
negative set employed. The frequencies of these features range
typically between 2 and 5; we could therefore use them directly as
input for the machine learning algorithms without the need of
further discretisation. A list of all features is given in Table S12.
Selection of the most discriminating features
To detect the most influential features, we applied two feature
selection strategies, a greedy hill-climbing search (the BestFirst
algorithm) (parameters: look-up-cache size=1, 5 iterations) in
combination with Correlated Feature Selection [54] (parameters:
locally predictive=true, missing values=false) as provided by
WEKA (version 3.5.6) [55].
Learning and testing procedure
We used the implementations of several classification algorithms
from the WEKA machine learning package. Each classifier has
Table 3. Mapping of amino acids to property alphabets.
Property Amino Acids
Hydrophobic; 1st alphabet A, G, I, L, M, V
Hydrophilic; 1st alphabet P, H, U
Aaromatic F,W,Y
Polar N, Q, S, T
Acidic D, E
Alkaline K, L, R
Ionisable C, Y
Hydrophilic; 2nd alphabet S, F, T, N, K, Y, E, Q, C, W, P, H, D, R, U
Hydrophobic; 2nd alphabet V, M, L, A, I, G
The mapping of amino acids on the two reduced alphabets (amino acid
property alphabet and hydrophobic/hydrophilic alphabet) maps each amino
acid to exactly one letter of the respective alphabet.
doi:10.1371/journal.ppat.1000376.t003
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sets) by a 10-fold cross-validation procedure as provided by
WEKA. For cross-validation, the positive and negative sequence
sets have been partitioned into 10 subsamples. In each of the 10
passes, a single subsample was retained as validation data for
testing the model which has been trained using the remaining 9
subsamples.
Initially, we aligned each N-terminus of the training set with
each other using the Smith-Waterman algorithm with a
BLOSUM62 substitution matrix. If two sequences showed Sratio
(see above).0.1 over the whole sequence or more than 0.3 in the
area of the signal, one of them was discarded from the training set.
This has been done to avoid learning protein-families instead of
the signal. Sensitivity has been computed as TP/(TP+FN),
Selectivity as TN/(TN+FP), with TP=amount true positive
predictions, FN=amount false negative predictions, TN=amount
true negative predictions, FP=amount false positive predictions.
Receiver Operating Statistics to determine the AUC value had
been created using the WEKA-toolbox. Precision and Recall are
computed separately for both classes, where the AUC describes
the overall performance of the classifier. The classification
algorithms employed are listed in Table 3.
Exploration of optimal position and length
To determine the optimal position and length of the signal we
applied a sliding window approach varying the start and length of
the sequence used for the learning and testing procedure. At each
position, the whole procedure of feature selection, removal of
similar sequences, training and cross-validation has been repeated.
For the position exploration, we used a window of the length 15
which we moved in steps of five residues. The length exploration
started with a window of the first ten residues which was elongated
by five residues in each round. If a sequence was too short for the
range of coordinates in a certain step of this procedure, it has been
discarded from the data set. Since we found that the choice of the
negative set does not significantly influence the prediction, we used
only one negative set in this analysis.
Signal robustness
The robustness of the signal has been assessed by measuring the
fractions of positively predicted instances from the training set
after introducing a certain amount of amino acid exchanges in the
first 25 residues. We only used these sequences, which are
predicted as true positives by the final classification algorithm (full
training set, Naı ¨ve Bayes algorithm with selective settings
[probability for class ‘‘secreted’’ .0.95 using the Naı ¨ve Bayesian
Classifier]).
We mutated the N-terminal sequences (first 25 residues) by
introducing point mutations at random positions into the
underlying DNA sequences (T,A,C,G exchanged with equal
probability of 1/4) which did not result in stop codons but altered
the amino acid sequence. After translating the mutated sequence,
we measured the fraction of positively predicted effectors after one,
five and ten consecutive mutations. In a second strategy we
substituted randomly selected amino acids according to their
importance for the TTSS signal peptide. Residues which did not
belong to the group of depleted amino acids (leucine, glutamic
acid, aspartic acid and alanine) were replaced by a randomly
selected member of this group of depleted amino acids. Residues
which did belong to the group of enriched amino acids (threonine,
serine and proline) were replaced by randomly selected amino
acids which did not belong to this group of enriched amino acids
(the substitution probabilities for the non-enriched amino acids
have been derived from their frequency within the complete
proteins without the N-terminal ends).
The effect of frame shift mutations on the signal
We have used a data set given by Ramamurthi et al. [56] of
three Yersinia effector proteins with three frame shift mutants for
each. We retrained our classifier using the first 15 amino acids
instead of the first 25, since only the first 15 residues of the mutants
are given in the paper.
Simulation of frame shifts has been done by shifting the DNA by
one (+1) and two (+2) positions. In order to get a sufficient amount
of sequences with sufficient length, appearing stop codons have
been replaced by methionine. We used only these effectors, which
show a positive prediction with restrictive parameters (probability
for class ‘‘secreted’’ .0.95 as reported by the Naı ¨ve Bayesian
Classifier). As control, we used randomly selected sequences from
the same organisms which are covered by the positive set and used
only these sequences, which were negatively predicted (probability
not secreted .0.95 as reported by the Naı ¨ve Bayesian Classifier).
Signals conserved after frame shift were detected with the same
settings as in the selection procedure.
Taxonomic universality of the signal
Notably, a conclusion about the signal’s generality cannot be
deduced by the fact that the classifier performs well in the cross-
validation procedure, since the algorithm might detect indepen-
dent features for each taxon in this procedure. In order to test the
universality of the signal, we excluded each taxon (Yersinia,
Salmonella, Escherichia, Chlamydia, Pseudomonas) from the training
and feature-selection procedure and tested the classifiers perfor-
mance with this taxon as separate test set. For both sets, negative
sets twice as large are randomly created from these organisms,
which are also in the respective positive set. The values for the
AUC have been computed using the WEKA-toolbox.
Final training of the classifier for the prediction of
secretomes
The final classifier has been obtained using both sets of known
effectors and a negative set which was twice as large as the positive
set. We used the Naı ¨ve Bayes algorithm as it showed the best
overall performance in the cross-validation procedure. Again, we
excluded similar N-termini and used the first 25 amino acids as
primary input. The sequence data of the proteomes has not been
pre-filtered or further processed for the prediction of effectors in
complete genomes. To investigate the influence of the amino acid
frequencies within each proteome, the prediction of effectors has
been also performed in pseudo-proteomes, for which all protein
sequences have been denaturised by random shuffling. The
shuffling process has altered only the order of amino acids within
the proteins but not their overall (genome-wide) frequency.
Implementation of the effectiveT3 software
The EffectiveT3 software is based on the WEKA toolbox and
implemented purely in the Java
TM programming language. The
probability threshold for class ‘‘secreted’’ using the Naı ¨ve Bayesian
Classifier can be selected by the user in order to adjust the
selectivity and sensitivity of the predictions. We offer a web-
interface for own predictions at http://www.chlamydiaedb.org.
Application of effectiveT3 to complete archaeal and
bacterial proteomes
Complete genome and proteome data of prokaryotic genomes
has been downloaded from the KEGG database [34] (release
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their association to the KEGG Orthologous Groups (KO)
belonging to the TTSS reference pathway KO03070
(K03219..K03230). Genomes in which at least 9 of these 12 KO
are present have been considered as genomes with TTSS.
Genomes in which less than 6 of these 12 KO are present have
been considered as genomes without TTSS. All genomes in which
between 6 and 8 of these 12 KO are present have been excluded
from this analysis to avoid uncertainty. Additionally, all bacterial
genomes have been excluded from this analysis for which no
information on cell wall type (Gram-positive vs. Gram-negative)
was available at the NCBI Entrez Genome Project Organism Info
database [38]. For the remaining 739 proteomes, EffectiveT3
predictions have been calculated using a selective parameter
setting (probability for class ‘‘secreted’’ .0.99 using the Naı ¨ve
Bayesian Classifier).
To estimate the enrichment of TTSS effector-like sequences in
the N-termini of the proteomes, a genome-wide Z-Score is
calculated for every proteome: Z=(N-A)/SD, whereas N denotes
the number of positives in the N-termini of the real proteome. A
and SD are derived from 50 repetitions predicting positives in
randomly chosen segments of 25 aa length (one segment per
protein), whereas A corresponds to the average number of
positives in the 50 runs and SD to their standard deviation.
Supporting Information
Figure S1 Example alignment of N-termini. The first 30
residues of non-homologous effector proteins have been aligned
using ClustalX with default parameters.
Found at: doi:10.1371/journal.ppat.1000376.s001 (4.31 MB TIF)
Figure S2 Example alignments between effector and non-
effector orthologs. To investigate the evolutionary acquisition of
the signal peptide, a pair wise sequence alignment study counting
individual elongations and truncations between effectors and non-
effector orthologs has been performed. This figure shows examples
of these alignments. A) demonstrates elongation and B) truncation
of effector proteins (upper row) aligned with sure non-effector
proteins (lower row).
Found at: doi:10.1371/journal.ppat.1000376.s002 (1.31 MB TIF)
Figure S3 Robustness of the TTSS secretion signal against point
mutations. The diagram depicts the percentage of positively
predicted TTSS signals after accumulation of point mutations.
The non-targeted mutation strategy exchanged residues accumu-
latively by random. The targeted mutation strategy favoured to
exchange these features, which we found to have the strongest
influence on the signal. For both experiments all positively
predicted proteins from the animal pathogen and plant symbiont
training sets have been used.
Found at: doi:10.1371/journal.ppat.1000376.s003 (0.09 MB TIF)
Table S1 Effector and TTSS sequences used in this study.
Effector proteins are listed first, then the sequences of the TTSS
system and few examples of TTSS related chaperones. The
different sets are denoted as follows: A=animal pathogen set,
P=plant symbiont set, T=type III secretion system, C=TTSS
related chaperone. For each sequence, the first 25 N-terminal
amino-acids are given.
Found at: doi:10.1371/journal.ppat.1000376.s004 (0.20 MB
DOC)
Table S2 Orthologous groups of effector proteins. This table
comprises effector proteins with individual experimental evidence
for type III mediated transport which can be clustered into
orthologous groups (clustered by homology and manual inspec-
tion). A sequence is added to a cluster, if it has at least
Sratio.=0.15 to one other cluster member. Sratio is computed as
alignment-score/selfscore.
Found at: doi:10.1371/journal.ppat.1000376.s005 (0.08 MB
DOC)
Table S3 Groups of co-evolving effector and TTSS proteins and
examples of co-localized effector proteins and chaperones based
on the STRING database. For each group of co-evolving effector
and TTSS proteins, gene names of the members are given. The
right column indicates, whether the orthologous group comprises
effectors, TTSS proteins or TTSS related chaperones. A gene is
added to a cluster, if the score of a genomic context method to
another member derived from STRING exceeds 0.5. In the last
section, examples of co-localized effectors and chaperones are
listed.
Found at: doi:10.1371/journal.ppat.1000376.s006 (0.05 MB
DOC)
Table S4 Number of genomic neighbours of known effectors,
number of non-neighbours and their association to the TTSS. For
all known effectors from Table S1, genomic neighbours have been
determined for a certain distance upstream and downstream on
the chromosome or plasmid. These neighbours and the remaining,
non-neighboured proteins of the genomes have been distinguished
by their association to the TTSS. Components of the TTSS are
enriched in the neighbourhood of effectors. The statistical
significance of this enrichment has been determined using the t-
Test. The most significant enrichment of TTSS components in the
genomic neighbourhood of effectors can be observed within the
range of 30 neighbours up- and downstream (marked in red).
Found at: doi:10.1371/journal.ppat.1000376.s007 (0.04 MB
DOC)
Table S5 Enrichment of KEGG orthologous groups within the
genomic neighbourhood of known effectors. This table lists
KEGG orthologous groups (KO), which are significantly enriched
(Bonferroni-corrected t-Test p-Value,0.05) within 30 neighbours
up- and downstream of known effectors.
Found at: doi:10.1371/journal.ppat.1000376.s008 (0.03 MB
DOC)
Table S6 Known effectors and their genomic neighbourhood to
TTSS components. The genomic neighbourhood (30 genes up-
and downstream) to TTSS components has been evaluated for all
known effectors, except on Yersinia pestis KIM due to the absence
of the plasmid pCD1 from the KEGG database. The number of
effectors which are neighboured to at least one TTSS component
is given in the middle column, the remaining effectors are
summarized in the right column.
Found at: doi:10.1371/journal.ppat.1000376.s009 (0.04 MB
DOC)
Table S7 Performance of the classifiers using the C-terminal
end. To prove the concept of the N-terminal signal peptide, C-
termini should have no predictive power. The performance for
several classifiers has been evaluated using exactly the same feature
selection, training and test procedure as used for the N-termini. 5
runs with different negative sets have been performed.
Found at: doi:10.1371/journal.ppat.1000376.s010 (0.03 MB
DOC)
Table S8 Prediction results with EffectiveT3 trained without a
certain taxonomic sub-set. EffectiveT3 has been trained without
the positive and negative samples from the excluded taxonomic
groups listed in this table. Testing EffectiveT3 on these effectors
(E) and randomly chosen negative samples (R) resulted in true
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negative (2R) predictions.
Found at: doi:10.1371/journal.ppat.1000376.s011 (0.35 MB
DOC)
Table S9 Pair wise comparison of orthologous effector and non-
effector proteins. Truncations, elongations and conservations of
the N-terminal length until the first functional domain are listed
according to the effector protein (first column) compared to
orthologs from non-TTSS bearing organisms.
Found at: doi:10.1371/journal.ppat.1000376.s012 (0.05 MB
DOC)
Table S10 Effector sequences which tolerate frame shift
mutations. The mutations were introduced by either shifting the
DNA sequences by one or two bases to the left, stop codons where
replaced by Methionine.
Found at: doi:10.1371/journal.ppat.1000376.s013 (0.04 MB
DOC)
Table S11 EffectiveT3 predictions in complete proteomes.
EffectiveT3 predictions for complete proteomes have been
grouped by Archaea, Gram-positive and Gram-negative bacteria.
Within each group, proteomes are sorted by their taxonomic
lineage and species names. For each proteome, the absence (2)o r
presence (+) of a TTSS, the genomic G+C content, the number of
annotated proteins, the percentage of EffectiveT3 positive
predictions and the genome-wide Z-Score are given. The presence
of the TTSS in the proteomes as determined by KEGG and the
hosts are coded by the following colors: black=without TTSS or
unknown host; red=with TTSS/animal pathogenic; green=with
TTSS/plant symbiotic.
Found at: doi:10.1371/journal.ppat.1000376.s014 (0.98 MB
DOC)
Table S12 Input features of the machine learning algorithms
after initial feature selection. This table comprises these features,
which are selected from all possible feature combinations using
three different alphabets (amino acid alphabet, amino acid
property alphabet, hydrophobic/hydrophilic alphabet) with a
maximal pattern length of three. In order to avoid over-fitting on
the data, only features are selected which are not specific to either
the positive or the negative set but exists in both.
Found at: doi:10.1371/journal.ppat.1000376.s015 (0.07 MB
DOC)
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